Recent studies have shown that blocking the METTL1-TGF-β2-PMN-MDSC axis can reduce the recurrence of HCC, further highlighting the importance of METTL1/WDR4 in HCC progression. This evidence concerns the gene TGFB2 and hepatocellular carcinoma.